Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: ANTINEOPLASTIC AGENTS - ADVERSE EFFECTS , . Treffer: 79

2019

Woltsche, N; El-Shabrawi-Caelen, L; Deinlein, T; Kupsa, R; Gschwandtner, M; Hofmann-Wellenhof, R; Zalaudek, I [Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma : A case report].
Hautarzt. 2019; 70(5):363-366 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Giuffrida, R; Kashofer, K; Dika, E; Patrizi, A; Baraldi, C; Di Meo, N; Zalaudek, I Fast growing melanoma following treatment with vismodegib for locally advanced basal cell carcinomas: report of two cases.
Eur J Cancer. 2018; 91(2):177-179 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2017

Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691
Web of Science PubMed FullText FullText_MUG

 

Sarny, S; Neumayer, M; Kofler, J; El-Shabrawi, Y Ocular toxicity due to Trametinib and Dabrafenib.
BMC Ophthalmol. 2017; 17(1):146-146 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Sezer, O; Beksac, M; Hajek, R; Sucak, G; Cagirgan, S; Linkesch, W; Meltem Akay, O; Gülbas, Z; Nahi, H; Plesner, T; Snowden, JA; Timurağaoğlu, A; Dechow, T; Lang, A; Tuğlular, T; Drach, J; Armbrecht, G; Potamianou, A; Couturier, C; Olie, RA; Feys, C; Allietta, N; Terpos, E Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol. 2017; 178(1):61-71
Web of Science PubMed FullText FullText_MUG

 

2016

Koch, L; Lichem, R; Cerroni, L; Aberer, W; Massone, C Dermatitis, nonmelanoma skin cancer and leg ulcers.
CLIN EXP DERMATOL. 2016; 41(8): 943-944. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Lee, SB; Weide, B; Ugurel, S; Mössner, R; Enk, A; Hassel, JC Vemurafenib-induced granuloma annulare.
J Dtsch Dermatol Ges. 2016; 14(3):305-308 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Prattes, J; Raggam, RB; Vanstraelen, K; Rabensteiner, J; Hoegenauer, C; Krause, R; Prüller, F; Wölfler, A; Spriet, I; Hoenigl, M Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?
J Clin Microbiol. 2016; 54(3):798-801 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Cerny-Reiterer, S; Rabenhorst, A; Stefanzl, G; Herndlhofer, S; Hoermann, G; Müllauer, L; Baumgartner, S; Beham-Schmid, C; Sperr, WR; Mannhalter, C; Sill, H; Linkesch, W; Arock, M; Hartmann, K; Valent, P Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.
Oncotarget. 2015; 6(5):3071-3084 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Drummond, A; Pichler, J; Argenziano, G; Zalaudek, I; Longo, C; Lallas, A; Piana, S; Moscarella, E Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome.
Australas J Dermatol. 2015; 56(4):e105-e107 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Grassi, L; Berardi, MA; Ruffilli, F; Meggiolaro, E; Andritsch, E; Sirgo, A; Caruso, R; Juan Linares, E; Bellé, M; Massarenti, S; Nanni, MG; IOR-IRST Psycho-Oncology and UniFE Psychiatry Co-Authors Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study.
Psychother Psychosom. 2015; 84(6):339-347 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Hoffmann, K; Ganten, T; Gotthardtp, D; Radeleff, B; Settmacher, U; Kollmar, O; Nadalin, S; Karapanagiotou-Schenkel, I; von Kalle, C; Jäger, D; Büchler, MW; Schemmer, P Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.
BMC Cancer. 2015; 15(11):392-392 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kremer, M; Manzini, G; Hristov, B; Polychronidis, G; Mokry, T; Sommer, CM; Mehrabi, A; Weitz, J; Büchler, MW; Schemmer, P Impact of Neoadjuvant Chemotherapy on Hypertrophy of the Future Liver Remnant after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy.
J Am Coll Surg. 2015; 221(3):717-728
Web of Science PubMed FullText FullText_MUG

 

Robert, C; Schachter, J; Long, GV; Arance, A; Grob, JJ; Mortier, L; Daud, A; Carlino, MS; McNeil, C; Lotem, M; Larkin, J; Lorigan, P; Neyns, B; Blank, CU; Hamid, O; Mateus, C; Shapira-Frommer, R; Kosh, M; Zhou, H; Ibrahim, N; Ebbinghaus, S; Ribas, A; KEYNOTE-006 investigators Pembrolizumab versus Ipilimumab in Advanced Melanoma.
N Engl J Med. 2015; 372(26):2521-2532 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Brämswig, K; Ploner, F; Martel, A; Bauernhofer, T; Hilbe, W; Kühr, T; Leitgeb, C; Mlineritsch, B; Petzer, A; Seebacher, V; Stöger, H; Girschikofsky, M; Hochreiner, G; Ressler, S; Romeder, F; Wöll, E; Brodowicz, T Sorafenib in advanced, heavily pretreated patients with soft tissue sarcomas.
Anticancer Drugs. 2014; 25(7):848-853
Web of Science PubMed FullText FullText_MUG

 

Gary, T Cancer related venous thromboembolism - prophylaxis and therapy.
Vasa. 2014; 43(4):245-251
Web of Science PubMed FullText FullText_MUG

 

Lozanovski, VJ; Houben, P; Hinz, U; Hackert, T; Herr, I; Schemmer, P Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial.
Trials. 2014; 15(2):204-204 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schrama, D; Groesser, L; Ugurel, S; Hafner, C; Pastrana, DV; Buck, CB; Cerroni, L; Theiler, A; Becker, JC Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations.
JAMA Dermatol. 2014; 150(11):1180-1186 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Ugurel, S; Mentzel, T; Utikal, J; Helmbold, P; Mohr, P; Pföhler, C; Schiller, M; Hauschild, A; Hein, R; Kämpgen, E; Kellner, I; Leverkus, M; Becker, JC; Ströbel, P; Schadendorf, D Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.
Clin Cancer Res. 2014; 20(2):499-510 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wutte, N; Palfner, M; Auer, H; Ruckenbauer, G; Valentin, T; Seeber, K; Aberer, W; Krause, R; Hoenigl, M Toxocarosis and putative DRESS syndrome in an oncological patient: a case report.
Wien Klin Wochenschr. 2014; 126 Suppl 1(2):S51-S55 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2013

Duvic, M; Dummer, R; Becker, JC; Poulalhon, N; Romero, PO; Bernengo, MG; Lebbe, C; Assaf, C; Squier, M; Williams, D; Marshood, M; Tai, F; Prince, HM; Panobinostat activity in both bexarotene-exposed and -naive patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial.
EUR J CANCER. 2013; 49(2): 386-394.
Web of Science PubMed FullText FullText_MUG

 

Gisondi, P; Cazzaniga, S; Chimenti, S; Giannetti, A; Maccarone, M; Picardo, M; Girolomoni, G; Naldi, L; Psocare Study Group Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry.
J Eur Acad Dermatol Venereol. 2013; 27(1):e30-e41
Web of Science PubMed FullText FullText_MUG

 

Müller, E; Seidel, MG; Lackner, H; Dworzak, M; Urban, C Acute promyelocytic leukemia complicated by massive intracerebral hemorrhage: safety and efficacy of replacing conventional chemotherapy with arsenic trioxide in an adolescent.
Klin Padiatr. 2013; 225(3):172-173 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Yamanaka, K; Petrulionis, M; Lin, S; Gao, C; Galli, U; Richter, S; Winkler, S; Houben, P; Schultze, D; Hatano, E; Schemmer, P Therapeutic potential and adverse events of everolimus for treatment of hepatocellular carcinoma - systematic review and meta-analysis.
Cancer Med. 2013; 2(6):862-871 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Bjelic-Radisic, V; Jensen, PT; Vlasic, KK; Waldenstrom, AC; Singer, S; Chie, W; Nordin, A; Greimel, E Quality of life characteristics inpatients with cervical cancer.
Eur J Cancer. 2012; 48(16):3009-3018
Web of Science PubMed FullText FullText_MUG

 

Flaherty, KT; Robert, C; Hersey, P; Nathan, P; Garbe, C; Milhem, M; Demidov, LV; Hassel, JC; Rutkowski, P; Mohr, P; Dummer, R; Trefzer, U; Larkin, JMG; Utikal, J; Dreno, B; Nyakas, M; Middleton, MR; Becker, JC; Casey, M; Sherman, LJ; Wu, FS; Ouellet, D; Martin, AM; Patel, K; Schadendorf, D; Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma.
N ENGL J MED. 2012; 367(2): 107-114. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gutzmer, R; Wollenberg, A; Ugurel, S; Homey, B; Ganser, A; Kapp, A Cutaneous side effects of new antitumor drugs: clinical features and management.
Dtsch Arztebl Int. 2012; 109(8):133-140 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pinter, M; Hucke, F; Graziadei, I; Vogel, W; Maieron, A; Königsberg, R; Stauber, R; Grünberger, B; Müller, C; Kölblinger, C; Peck-Radosavljevic, M; Sieghart, W Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
Radiology. 2012; 263(2):590-599 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rainer, PP; Doleschal, B; Kirk, JA; Sivakumaran, V; Saad, Z; Groschner, K; Maechler, H; Hoefler, G; Bauernhofer, T; Samonigg, H; Hutterer, G; Kass, DA; Pieske, B; von Lewinski, D; Pichler, M Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes.
BJU Int. 2012; 110(10):1455-1462 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Stupp, R; Wong, ET; Kanner, AA; Steinberg, D; Engelhard, H; Heidecke, V; Kirson, ED; Taillibert, S; Liebermann, F; Dbaly, V; Ram, Z; Villano, JL; Rainov, N; Weinberg, U; Schiff, D; Kunschner, L; Raizer, J; Honnorat, J; Sloan, A; Malkin, M; Landolfi, JC; Payer, F; Mehdorn, M; Weil, RJ; Pannullo, SC; Westphal, M; Smrcka, M; Chin, L; Kostron, H; Hofer, S; Bruce, J; Cosgrove, R; Paleologous, N; Palti, Y; Gutin, PH NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Eur J Cancer. 2012; 48(14):2192-2202 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Eschenhagen, T; Force, T; Ewer, MS; de Keulenaer, GW; Suter, TM; Anker, SD; Avkiran, M; de Azambuja, E; Balligand, JL; Brutsaert, DL; Condorelli, G; Hansen, A; Heymans, S; Hill, JA; Hirsch, E; Hilfiker-Kleiner, D; Janssens, S; de Jong, S; Neubauer, G; Pieske, B; Ponikowski, P; Pirmohamed, M; Rauchhaus, M; Sawyer, D; Sugden, PH; Wojta, J; Zannad, F; Shah, AM Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
EUR J HEART FAIL. 2011; 13(1): 1-10. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Gutzmer, R; Becker, JC; Enk, A; Garbe, C; Hauschild, A; Leverkus, M; Reimer, G; Treudler, R; Tsianakas, A; Ulrich, C; Wollenberg, A; Homey, B Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician.
J Dtsch Dermatol Ges. 2011; 9(3):195-202 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Henke, M; Alfonsi, M; Foa, P; Giralt, J; Bardet, E; Cerezo, L; Salzwimmer, M; Lizambri, R; Emmerson, L; Chen, MG; Berger, D Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
J CLIN ONCOL. 2011; 29(20): 2815-2820. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Le, QT; Kim, HE; Schneider, CJ; Murakozy, G; Skladowski, K; Reinisch, S; Chen, Y; Hickey, M; Mo, M; Chen, MG; Berger, D; Lizambri, R; Henke, M Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
J CLIN ONCOL. 2011; 29(20): 2808-2814. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mikalauskas, S; Mikalauskiene, L; Bruns, H; Nickkholgh, A; Hoffmann, K; Longerich, T; Strupas, K; Büchler, MW; Schemmer, P Dietary glycine protects from chemotherapy-induced hepatotoxicity.
Amino Acids. 2011; 40(4):1139-1150
Web of Science PubMed FullText FullText_MUG

 

Sill, H; Olipitz, W; Zebisch, A; Schulz, E; Wölfler, A Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
Br J Pharmacol. 2011; 162(4): 792-805. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2010

Hanzer, M; Nebl, A; Spendel, S; Pilhatsch, A; Urban, C; Benesch, M Necrosis of a skin autograft after short-term treatment with sunitinib in a 14-year-old girl with metastatic alveolar soft part sarcoma of the thigh.
Klin Padiatr. 2010; 222(3): 184-186.
Web of Science PubMed FullText FullText_MUG

 

2009

Gnant, M; Dubsky, P; Fitzal, F; Blaha, P; Schoppmann, S; Steger, G; Marth, C; Samonigg, H; Hüttner, K; Fohler, H; Ruecklinger, E; Jakesz, R; Greil, R; Austrian Breast and Colorectal Cancer Study Group Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Clin Breast Cancer. 2009; 9 Suppl 1: S18-S27.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Haxhija, EQ; Lackner, H; Höllwarth, ME Medical treatment of children with hemangiomas and its limitations
Handchir Mikrochir Plast Chir. 2009; 41(2): 78-82.
Web of Science PubMed FullText FullText_MUG

 

Mlineritsch, B; Schabel-Moser, R; Andel, J; Fridrik, M; Moik, M; Mayer, P; Russ, G; Rass, C; Greil, R; Arbeitsgemeinschaft medikamentöse Tumortherapie Study Group Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Onkologie. 2009; 32(1-2):18-24
Web of Science PubMed FullText FullText_MUG

 

2008

Beer, M; Stenzel, M; Girschick, H; Schlegel, PG; Dargel, K Whole-body MR imaging in children with suspected osteonecrosis after intensive chemotherapy: Preliminary results
Rofo. 2008; 180(3):238-245
Web of Science PubMed FullText FullText_MUG

 

Hauschild, A; Trefzer, U; Garbe, C; Kaehler, KC; Ugurel, S; Kiecker, F; Eigentler, T; Krissel, H; Schott, A; Schadendorf, D Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma.
Melanoma Res. 2008; 18(4):274-278
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Petru, E; Andel, J; Angleitner-Boubenizek, L; Steger, G; Bernhart, M; Busch, K; Gehmacher, O; Hernler, T; Kastner, U; Lanz-Veit, A; Pluschnigg, U; Polachova, J; Rohde, M; Schiller, L; Schramböck, R; Stangl, W; Thödtmann, R; Zabernigg, A Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy.
Wien Med Wochenschr. 2008; 158(5-6): 169-173.
PubMed FullText FullText_MUG Google Scholar

 

Pföhler, C; Ugurel, S Cutaneous reactions to molecular targeted therapies.
Hautarzt. 2008; 59(10):814-820
Web of Science PubMed FullText FullText_MUG

 

Ulrich, J; Hartmann, JT; Dörr, W; Ugurel, S Skin toxicity of anti-cancer therapy.
J Dtsch Dermatol Ges. 2008; 6(11):959-977
PubMed FullText FullText_MUG

 

2007

Gnant, MF; Mlineritsch, B; Luschin-Ebengreuth, G; Grampp, S; Kaessmann, H; Schmid, M; Menzel, C; Piswanger-Soelkner, JC; Galid, A; Mittlboeck, M; Hausmaninger, H; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2007; 25(7): 820-828. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

von Delius, S; Eckel, F; Wagenpfeil, S; Mayr, M; Stock, K; Kullmann, F; Obermeier, F; Erdmann, J; Schmelz, R; Quasthoff, S; Adelsberger, H; Bredenkamp, R; Schmid, RM; Lersch, C Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study.
Invest New Drugs. 2007; 25(2):173-180
Web of Science PubMed FullText FullText_MUG

 

2006

Benesch, M; Lackner, H; Sovinz, P; Suppan, E; Schwinger, W; Eder, HG; Dornbusch, HJ; Moser, A; Triebl-Roth, K; Urban, C Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003.
J Neurooncol. 2006; 78(2):199-205
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Fiegl, M; Falkner, A; Hopfinger, G; Brugger, S; Zabernigg, A; Bauer, F; Haslbauer, F; Demirtas, D; Grossschmidt, P; Tatzreiter, G; Gastl, G; Greil, R; Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukemia Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in Austria.
CANCER. 2006; 107(10): 2408-2416. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kerbl, R; Urban, CE; Zotter, H; Dornbusch, HJ; Ladenstein, R; Ambros, IM; Ambros, PF Treatment complications in neuroblastoma patients: lessons from screening studies.
J Clin Oncol. 2006; 24(21): e41-e41. [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum